- Urapidil (International database) - Drugs. com
Urapidil is a medicine available in a number of countries worldwide A list of US medications equivalent to Urapidil is available on the Drugs com website
- Ebrantil: Uses, Dosage, Side Effects, Food Interaction FAQ
Ebrantil is a combination adrenergic antagonist and serotonin agonist given orally for the treatment of essential hypertension and intravenously in hypertensive emergencies
- EBRANTIL Capsules 15mg | Kusuri-no-Shiori (Drug Information Sheet)
To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment This medicine dilates peripheral vessels and lowers blood pressure by its antagonistic action on alpha-1 receptors
- EBRANTIL Capsules 15mg | myHealthbox
BRAND NAME: EBRANTIL CAPSULES 15MG ACTIVE INGREDIENT: Urapidil DOSAGE FORM: white capsule (major axis: 11 4 mm, minor axis: 4 9 mm) PRINT ON WRAPPING: EBRANTILCap 15mg, エブランチルカプセル 15, 15mg, KC155 EFFECTS OF THIS MEDICINE This medicine dilates peripheral vessels and lowers blood pressure by its antagonistic action on alpha-1
- Ebrantil Drug Information [ Altana Pharma; Byk; Nycomed ]
Ebrantil drug manufacturers and companies such as Altana Pharma; Byk; Nycomed Ebrantil active ingredients, usages, indications, composition, dosages and other pharmaceutical product information
- EBRANTIL - Drug - RxReasoner
This brand name is authorized in Austria, Croatia, Germany, Japan, Poland, Turkey The drug EBRANTIL contains one active pharmaceutical ingredient (API): Urapidil is a α1-adrenoceptor antagonist and 5-HT1A receptor agonist and consequently inhibits the vasoconstrictor effect of catecholamines
- Ebrantil | Drug Information, Uses, Side Effects, Chemistry . . .
Know about technical details of Ebrantil like: chemical name, chemistry structure, formulation, uses, toxicity, action, side effects and more at Pharmacompass com
- Instructions for use and Summary of product characteristics Ebrantil i . . .
The antihypertensive effect of Ebrantil i v 25 mg may be potentiated by concomitant administration use of alpha receptor blockers, vasodilators and other hypotensive agents or alcohol, as well as in volume-depleted patients (diarrhoea, vomiting)
|